Patients in Mississippi, where Ivim reportedly does not operate, will also need to look elsewhere
Gonzlez-Fuentes J, Selva J, Moya C, et al
Research shows that 40 mg daily works well for many, though some need up to 60 mg for optimal relief
These results from the Phase II trial could lead to clinically meaningful benefits for cardiovascular, renal, and metabolic diseases, Boehringer Ingelheim suggests
Unimolecular multi-receptor agonist A single molecular entity engineered to activate two or more distinct receptors
Specifically, if you have suffered nonarteritic ischemis optic neuropathy (NAION) and took either of these drugs you likely qualify to file suit